Net Income Increased
Raises Fiscal Year 2026 Guidance for
Second Quarter and Year-to-Date 2026 Highlights Compared to Prior Year Period
- Net sales were
$216 million , an increase of$47 million , or 28%, in the second quarter and$396 million year-to-date, an increase of$96 million , or 32%. Vita Coco Coconut Water net sales grew 21% in the second quarter and 29% year-to-date.- Gross profit was
$105 million in the second quarter, an increase of$44 million , and$177 million year-to-date, an increase of$68 million . - Gross margin was 49% of net sales in the second quarter compared to 36%, and 45% of net sales year-to-date compared to 36%, with tariff refunds delivering a 700 basis point benefit to gross margin in the second quarter and 300 basis point benefit year-to-date.
- Net income was
$49 million in the second quarter compared to$23 million , an increase of$27 million , and$80 million year-to-date compared to$42 million , an increase of$38 million . - Net income per diluted share was
$0.82 in the second quarter compared to$0.38 , and$1.32 per diluted share year-to-date compared to$0.70 . - Non-GAAP Adjusted EBITDA1 was $67 million in the second quarter compared to $29 million, an increase of
$38 million . Non-GAAP Adjusted EBITDA1 was $106 million year-to-date, compared to $52 million, an increase of$54 million .
Second Quarter 2026 Consolidated Results
Net sales increased $47 million, or 28%, to $216 million for the second quarter ended
Gross profit increased to $105 million, from $61 million in the prior year period driven by the recognition of tariff refunds, higher sales, favorable pricing, alongside lower ocean freight and finished goods costs, partially offset by slightly higher domestic logistics costs. Gross margin was 49% compared to 36% in the prior year period. The increase resulted primarily from the tariff refunds, higher net pricing alongside lower ocean freight rates and finished goods costs, slightly offset by higher domestic transportation costs.
Selling, general and administrative ("SG&A") expenses were $42 million, compared to $36 million in the prior year period. The increase was primarily driven by higher people-related costs reflecting increased incentive compensation, headcount growth, and stock-based compensation, as well as investments in sales and marketing.
Net income was $49 million, or
Non-GAAP Adjusted EBITDA1 was $67 million, compared to $29 million in the prior year due to the increased gross profit partially offset by higher SG&A expenses.
Balance Sheet
As of
As of
Acquisition of
On
Fiscal Year 2026 Full Year Outlook
The Company is increasing its full year 2026 guidance, which includes balance of year for Copra, as follows:
- Net sales expected to be between
$790 million and$805 million , driven by high teens to twenty percent growth ofVita Coco Coconut Water and strong Private Label trends from new and regained business. (Prior guidance was between$720 million and$735 million ). - Gross margin expected to be approximately 40% with benefit relative to prior year from tariff refunds, higher pricing and lower ocean freight partially offset by increased product costs and adverse product mix. (Prior guidance was 38%).
- Expect to deliver SG&A leverage of one percentage point of sales vs. 2025. (Prior guidance high single digit percentage growth).
- Adjusted EBITDA1 expected to be in the range of
$154 million to$161 million . (Prior guidance was between$132 million and$138 million ).
Uncertainty and instability in the current operating environment, geopolitical landscape, and global economies, including the military conflict in
Footnotes
| (1) | Adjusted EBITDA represents earnings before interest, taxes, depreciation, and amortization as adjusted for certain items as set forth in the reconciliation table of U.S. GAAP to non-GAAP information and is a measure calculated and presented on the basis of methodologies other than in accordance with GAAP. Please refer to the Non-GAAP Financial Measures herein for further discussion and reconciliation of this measure to GAAP measures. | |
| (2) | GAAP Net income 2026 outlook is not provided due to the inherent difficulty in quantifying certain amounts due to a variety of factors including the unpredictability in the movement in foreign currency rates, as well as future charges or reversals outside of the normal course of business. | |
Conference Call and Webcast Details
To participate in the live earnings call and question and answer session, please register at https://register-conf.media-server.com/register/BIeb66856a8514488b970c774b5cc0004d and dial-in information will be provided directly to you. The live audio webcast will be accessible in the “Events” section of the Company’s Investor Relations website at https://investors.thevitacococompany.com/. An archived replay of the webcast will be available shortly after the live event has concluded.
About The Vita Coco Company
The Vita Coco Company is a family of brands on a mission to reimagine what’s possible when brands deliver healthy, nutritious, and great tasting products that are better for consumers and better for the world. This includes its flagship coconut water brand Vita Coco, and protein-infused water PWR LIFT. The Company was co-founded in 2004 by Michael Kirban and Ira Liran and is a public benefit corporation and Certified B Corporation. Vita Coco, the principal brand within the Company’s portfolio, is the leading coconut water brand in the U.S. With electrolytes, nutrients, and vitamins, coconut water has become a top beverage choice among consumers after a workout, in smoothies, as a cocktail mixer, after a night out, and more.
Contacts
Investor Relations:
ICR, Inc.
investors@thevitacococompany.com
Non-GAAP Financial Measures
In addition to disclosing results determined in accordance with U.S. GAAP, the Company also discloses certain non-GAAP results of operations, including, but not limited to, Adjusted EBITDA, that include certain adjustments or exclude certain charges and gains that are described in the reconciliation table of U.S. GAAP to non-GAAP information provided at the end of this release. These non-GAAP measures are a key metric used by management and our board of directors to assess our financial performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance and because we believe it is useful for investors to see the measures that management uses to evaluate the Company. In addition, we believe the presentation of these measures is useful to investors for period-to-period comparisons of results as the items described below in the reconciliation tables do not reflect ongoing operating performance.
These measures are not in accordance with, or an alternative to, U.S. GAAP, and may be different from non-GAAP measures used by other companies. In addition, other companies, including companies in our industry, may calculate such measures differently, which reduces their usefulness as a comparative measure. Investors should not rely on any single financial measure when evaluating our business. This information should be considered as supplemental in nature and is not meant as a substitute for our operating results in accordance with U.S. GAAP. We recommend investors review the U.S. GAAP financial measures included in this earnings release. When viewed in conjunction with our U.S. GAAP results and the accompanying reconciliations, we believe these non-GAAP measures provide greater transparency and a more complete understanding of factors affecting our business than U.S. GAAP measures alone.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, but not limited to, statements regarding our future financial and operating performance, including our GAAP and non-GAAP guidance, our strategy, projected costs, tariffs, prospects, expectations, plans, objectives of management, supply chain predictions, customer and supplier relationships, expected impact of acquisitions, and expected net sales and category share growth.
The forward-looking statements in this release are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond the Company’s control. These factors include, but are not limited to, those discussed under the caption “Risk Factors” in our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and our other filings with the U.S. Securities and Exchange Commission ("SEC") as such factors may be updated from time to time and which are accessible on the SEC’s website at www.sec.gov and the Investor Relations page of our website at https://investors.thevitacococompany.com. Any forward-looking statements contained in this press release speak only as of the date hereof and accordingly undue reliance should not be placed on such statements. We disclaim any obligation or undertaking to update or revise any forward-looking statements contained in this press release, whether as a result of new information, future events or otherwise, other than to the extent required by applicable law.
Website Disclosure
We intend to use our websites, vitacoco.com and investors.thevitacococompany.com, as a means for disclosing material non-public information and for complying with the SEC's Regulation FD and other disclosure obligations.
| THE CONDENSED CONSOLIDATED BALANCE SHEETS (Amounts in thousands, except share data) | |||||||
2026 | 2025 | ||||||
| Assets | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 278,640 | $ | 196,873 | |||
| Accounts receivable, net of allowance of | 132,312 | 81,514 | |||||
| Inventory | 82,911 | 111,468 | |||||
| Supplier advances, current | 452 | 693 | |||||
| Derivative assets | 2,940 | 732 | |||||
| Prepaid expenses and other current assets | 37,775 | 30,160 | |||||
| Total current assets | 535,030 | 421,440 | |||||
| Property and equipment, net | 8,931 | 9,298 | |||||
| 7,791 | 7,791 | ||||||
| Supplier advances, long-term | 1,692 | 1,860 | |||||
| Deferred tax assets, net | 6,466 | 6,463 | |||||
| Right-of-use assets, net | 10,643 | 11,592 | |||||
| Other assets | 2,389 | 2,714 | |||||
| Total assets | $ | 572,942 | $ | 461,158 | |||
| Liabilities and Stockholders’ Equity | |||||||
| Current liabilities: | |||||||
| Accounts payable | $ | 30,975 | $ | 25,464 | |||
| Accrued expenses and other current liabilities | 127,330 | 89,461 | |||||
| Derivative liabilities | 1,121 | 1,507 | |||||
| Total current liabilities | 159,426 | 116,432 | |||||
| Operating lease liability, long-term | 12,520 | 13,087 | |||||
| Other long-term liabilities | 92 | 97 | |||||
| Total liabilities | $ | 172,038 | $ | 129,616 | |||
| Stockholders’ equity: | |||||||
| Common stock, | 649 | 642 | |||||
| Additional paid-in capital | 195,611 | 185,400 | |||||
| Retained earnings | 307,939 | 228,014 | |||||
| Accumulated other comprehensive gain (loss) | (287 | ) | 486 | ||||
| (103,008 | ) | (83,000 | ) | ||||
| Total stockholders’ equity | 400,904 | 331,542 | |||||
| Total liabilities and stockholders’ equity | $ | 572,942 | $ | 461,158 | |||
| THE CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Amounts in thousands, except for share and per share data) | |||||||||||||
| Three Months Ended | Six Months Ended | ||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||
| Net sales | $ | 216,153 | $ | 168,759 | $ | 395,918 | $ | 299,680 | |||||
| Cost of goods sold | 110,842 | 107,494 | 218,794 | 190,330 | |||||||||
| Gross profit | 105,311 | 61,265 | 177,124 | 109,350 | |||||||||
| Operating expenses | |||||||||||||
| Selling, general and administrative | 42,172 | 36,143 | 80,403 | 64,935 | |||||||||
| Income from operations | 63,139 | 25,122 | 96,721 | 44,415 | |||||||||
| Other income (expense) | |||||||||||||
| Unrealized (loss) gain on derivative instruments | (233 | ) | 1,067 | 2,594 | 3,884 | ||||||||
| Foreign currency (loss) gain | (1,046 | ) | 482 | (1,545 | ) | 1,062 | |||||||
| Interest income, net | 2,483 | 1,500 | 4,021 | 3,018 | |||||||||
| Other income, net | 14 | — | 8 | 155 | |||||||||
| Total other income | 1,218 | 3,049 | 5,078 | 8,119 | |||||||||
| Income before income taxes | 64,357 | 28,171 | 101,799 | 52,534 | |||||||||
| Income tax expense | 14,906 | 5,263 | 21,874 | 10,744 | |||||||||
| Net income | $ | 49,451 | $ | 22,908 | $ | 79,925 | $ | 41,790 | |||||
| Net income attributable to The | |||||||||||||
| Basic | $ | 0.86 | $ | 0.40 | $ | 1.40 | $ | 0.73 | |||||
| Diluted | $ | 0.82 | $ | 0.38 | $ | 1.32 | $ | 0.70 | |||||
| Weighted-average number of common shares outstanding | |||||||||||||
| Basic | 57,251,361 | 56,795,499 | 57,183,296 | 56,894,274 | |||||||||
| Diluted | 60,642,797 | 59,643,348 | 60,390,598 | 59,809,039 | |||||||||
| THE CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Amounts in thousands) | |||||||
| Six Months Ended | |||||||
| 2026 | 2025 | ||||||
| Cash flows from operating activities: | |||||||
| Net income | $ | 79,925 | $ | 41,790 | |||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
| Depreciation and amortization | 965 | 408 | |||||
| Amortization of debt issuance cost | 9 | 6 | |||||
| (Decrease) increase of provision for credit losses | (829 | ) | 608 | ||||
| Unrealized (gain) on derivative instruments | (2,594 | ) | (3,884 | ) | |||
| Stock-based compensation | 8,216 | 5,148 | |||||
| Noncash lease expense | 935 | 747 | |||||
| Changes in operating assets and liabilities: | |||||||
| Accounts receivable | (50,590 | ) | (37,758 | ) | |||
| Inventory | 28,309 | 127 | |||||
| Prepaid expenses, net supplier advances, and other assets | (7,175 | ) | (1,454 | ) | |||
| Accounts payable, accrued expenses, and other liabilities | 39,358 | 6,272 | |||||
| Net cash provided by operating activities | 96,529 | 12,010 | |||||
| Cash flows from investing activities: | |||||||
| Cash paid for property and equipment | (612 | ) | (1,508 | ) | |||
| Net cash used in investing activities | (612 | ) | (1,508 | ) | |||
| Cash flows from financing activities: | |||||||
| Proceeds from exercise of stock awards | 6,112 | 977 | |||||
| Cash paid on notes payable | (3 | ) | (5 | ) | |||
| Cash paid to acquire treasury stock | (20,008 | ) | (10,053 | ) | |||
| Net cash used in financing activities | (13,899 | ) | (9,081 | ) | |||
| Effects of exchange rate changes on cash and cash equivalents | (246 | ) | 961 | ||||
| Net increase in cash and cash equivalents | 81,772 | 2,382 | |||||
| Cash, cash equivalents and restricted cash at beginning of the period (1) | 198,154 | 165,933 | |||||
| Cash, cash equivalents and restricted cash at end of the period (1) | $ | 279,926 | 168,315 | ||||
1 Includes
RECONCILIATION FROM GAAP NET INCOME TO NON-GAAP ADJUSTED EBITDA
| Three Months Ended | Six Months Ended | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| (in thousands) | (in thousands) | ||||||||||||||
| Net income | 49,451 | 22,908 | $ | 79,925 | $ | 41,790 | |||||||||
| Depreciation and amortization | 489 | 206 | 965 | 408 | |||||||||||
| Interest income, net | (2,483 | ) | (1,500 | ) | (4,021 | ) | (3,018 | ) | |||||||
| Income tax expense | 14,906 | 5,263 | 21,874 | 10,744 | |||||||||||
| EBITDA | $ | 62,363 | $ | 26,877 | $ | 98,743 | $ | 49,924 | |||||||
| Stock-based compensation (a) | 3,590 | 2,962 | 8,216 | 5,148 | |||||||||||
| Unrealized loss (gain) on derivative instruments (b) | 233 | (1,067 | ) | (2,594 | ) | (3,884 | ) | ||||||||
| Foreign currency loss (gain) (b) | 1,046 | (482 | ) | 1,545 | (1,062 | ) | |||||||||
| Other adjustments (c) | — | 952 | — | 1,621 | |||||||||||
| Adjusted EBITDA | $ | 67,232 | $ | 29,242 | $ | 105,910 | $ | 51,747 | |||||||
| (a) | Non-cash charges related to stock-based compensation, which vary from period to period depending on volume and vesting timing of awards and forfeitures. We adjusted for these charges to facilitate comparison from period to period. | |
| (b) | Unrealized gains or losses on derivative instruments and foreign currency gains or losses are not considered in our evaluation of our ongoing performance. | |
| (c) | The three and six months ended | |
SUPPLEMENTAL INFORMATION
| Three Months Ended | Six Months Ended | ||||||||||
| (in thousands) | 2026 | 2025 | 2026 | 2025 | |||||||
| Vita Coco Coconut Water | $ | 137,921 | $ | 120,450 | $ | 255,954 | $ | 206,568 | |||
| Private Label | 26,901 | 14,685 | 51,301 | 35,882 | |||||||
| Other | 7,643 | 6,826 | 13,374 | 12,111 | |||||||
| Subtotal | $ | 172,465 | $ | 141,961 | $ | 320,629 | $ | 254,561 | |||
| International segment | |||||||||||
| Vita Coco Coconut Water | $ | 31,763 | $ | 19,882 | $ | 54,283 | $ | 33,059 | |||
| Private Label | 11,328 | 6,222 | 20,165 | 10,981 | |||||||
| Other | 597 | 694 | 841 | 1,079 | |||||||
| Subtotal | $ | 43,688 | $ | 26,798 | $ | 75,289 | $ | 45,119 | |||
| Total net sales | $ | 216,153 | $ | 168,759 | $ | 395,918 | $ | 299,680 | |||
| COST OF GOODS SOLD & GROSS PROFIT | |||||||||||||||
| Three Months Ended | Six Months Ended | ||||||||||||||
| (in thousands) | 2026 | 2025 | 2026 | 2025 | |||||||||||
| Cost of goods sold | |||||||||||||||
| $ | 83,185 | $ | 90,915 | $ | 170,415 | $ | 161,203 | ||||||||
| International segment | 27,657 | 16,579 | 48,379 | 29,127 | |||||||||||
| Total cost of goods sold | $ | 110,842 | $ | 107,494 | $ | 218,794 | $ | 190,330 | |||||||
| Gross profit | |||||||||||||||
| $ | 89,281 | $ | 51,046 | $ | 150,215 | $ | 93,358 | ||||||||
| International segment | 16,030 | 10,219 | 26,909 | 15,992 | |||||||||||
| Total gross profit | $ | 105,311 | $ | 61,265 | $ | 177,124 | $ | 109,350 | |||||||
| Gross margin | |||||||||||||||
| 51.8 | % | 36.0 | % | 46.9 | % | 36.7 | % | ||||||||
| International segment | 36.7 | % | 38.1 | % | 35.7 | % | 35.4 | % | |||||||
| Consolidated | 48.7 | % | 36.3 | % | 44.7 | % | 36.5 | % | |||||||
| VOLUME (CE) | ||||||||
| Percentage Change - Three Months Ended | ||||||||
| International segment | Total | |||||||
| Vita Coco Coconut Water | 6.6 | % | 60.3 | % | 15.0 | % | ||
| Private Label | 81.7 | % | 71.0 | % | 78.1 | % | ||
| Other | 4.7 | % | (78.5 | )% | 1.9 | % | ||
| Subtotal | 16.1 | % | 62.2 | % | 24.3 | % | ||
| Percentage Change - Six Months Ended | ||||||||
| International segment | Total | |||||||
| Vita Coco Coconut Water | 16.0 | % | 53.7 | % | 22.1 | % | ||
| Private Label | 44.1 | % | 66.9 | % | 50.2 | % | ||
| Other | 8.8 | % | (33.5 | )% | 7.4 | % | ||
| Subtotal | 20.5 | % | 57.0 | % | 26.9 | % | ||
Note: A CE is a standard volume measure used by management which is defined as a case of 12 bottles of 330ml liquid beverages or the same liter volume of oil. We may have immaterial sales of raw materials at times that are treated as zero CEs for the purposes of these calculations.
Source: The 